KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adaptive Biotechnologies (ADPT) Total Current Liabilities: 2018-2024

Historic Total Current Liabilities for Adaptive Biotechnologies (ADPT) over the last 7 years, with Dec 2024 value amounting to $98.1 million.

  • Adaptive Biotechnologies' Total Current Liabilities fell 4.87% to $83.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $83.4 million, marking a year-over-year decrease of 4.87%. This contributed to the annual value of $98.1 million for FY2024, which is 11.40% up from last year.
  • Per Adaptive Biotechnologies' latest filing, its Total Current Liabilities stood at $98.1 million for FY2024, which was up 11.40% from $88.0 million recorded in FY2023.
  • Adaptive Biotechnologies' 5-year Total Current Liabilities high stood at $113.8 million for FY2021, and its period low was $88.0 million during FY2023.
  • For the 3-year period, Adaptive Biotechnologies' Total Current Liabilities averaged around $98.6 million, with its median value being $98.1 million (2024).
  • Its Total Current Liabilities has fluctuated over the past 5 years, first skyrocketed by 34.33% in 2020, then dropped by 19.83% in 2023.
  • Over the past 5 years, Adaptive Biotechnologies' Total Current Liabilities (Yearly) stood at $105.2 million in 2020, then rose by 8.18% to $113.8 million in 2021, then decreased by 3.53% to $109.8 million in 2022, then fell by 19.83% to $88.0 million in 2023, then increased by 11.40% to $98.1 million in 2024.